Research ArticleArticle
Altered Natural Killer Cell Subsets in Seropositive Arthralgia and Early Rheumatoid Arthritis are Associated with Autoantibody Status
Paulina Chalan, Johan Bijzet, Bart-Jan Kroesen, Annemieke M.H. Boots and Elisabeth Brouwer
The Journal of Rheumatology April 2016, jrheum.150644; DOI: https://doi.org/10.3899/jrheum.150644
Paulina Chalan
From the Department of Rheumatology and Clinical Immunology, and the Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. Supported by the Groningen University Institute for Drug Exploration. P. Chalan, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen; J. Bijzet, BS, Department of Rheumatology and Clinical Immunology, University of Groningen; E. Brouwer, MD, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen; A.M. Boots, Prof., Department of Rheumatology and Clinical Immunology, University of Groningen; B.J. Kroesen, PhD, Department of Laboratory Medicine, University of Groningen. Address correspondence to Prof. A.M. Boots, University Medical Center Groningen, Department of Rheumatology and Clinical Immunology, Hanzeplein 1, AA21 Groningen, 9713 GZ, the Netherlands. E-mail: m.boots@umcg.nl. Accepted for publication February 5, 2016.
Johan Bijzet
From the Department of Rheumatology and Clinical Immunology, and the Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. Supported by the Groningen University Institute for Drug Exploration. P. Chalan, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen; J. Bijzet, BS, Department of Rheumatology and Clinical Immunology, University of Groningen; E. Brouwer, MD, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen; A.M. Boots, Prof., Department of Rheumatology and Clinical Immunology, University of Groningen; B.J. Kroesen, PhD, Department of Laboratory Medicine, University of Groningen. Address correspondence to Prof. A.M. Boots, University Medical Center Groningen, Department of Rheumatology and Clinical Immunology, Hanzeplein 1, AA21 Groningen, 9713 GZ, the Netherlands. E-mail: m.boots@umcg.nl. Accepted for publication February 5, 2016.
Bart-Jan Kroesen
From the Department of Rheumatology and Clinical Immunology, and the Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. Supported by the Groningen University Institute for Drug Exploration. P. Chalan, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen; J. Bijzet, BS, Department of Rheumatology and Clinical Immunology, University of Groningen; E. Brouwer, MD, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen; A.M. Boots, Prof., Department of Rheumatology and Clinical Immunology, University of Groningen; B.J. Kroesen, PhD, Department of Laboratory Medicine, University of Groningen. Address correspondence to Prof. A.M. Boots, University Medical Center Groningen, Department of Rheumatology and Clinical Immunology, Hanzeplein 1, AA21 Groningen, 9713 GZ, the Netherlands. E-mail: m.boots@umcg.nl. Accepted for publication February 5, 2016.
Annemieke M.H. Boots
From the Department of Rheumatology and Clinical Immunology, and the Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. Supported by the Groningen University Institute for Drug Exploration. P. Chalan, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen; J. Bijzet, BS, Department of Rheumatology and Clinical Immunology, University of Groningen; E. Brouwer, MD, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen; A.M. Boots, Prof., Department of Rheumatology and Clinical Immunology, University of Groningen; B.J. Kroesen, PhD, Department of Laboratory Medicine, University of Groningen. Address correspondence to Prof. A.M. Boots, University Medical Center Groningen, Department of Rheumatology and Clinical Immunology, Hanzeplein 1, AA21 Groningen, 9713 GZ, the Netherlands. E-mail: m.boots@umcg.nl. Accepted for publication February 5, 2016.
Elisabeth Brouwer
From the Department of Rheumatology and Clinical Immunology, and the Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands. Supported by the Groningen University Institute for Drug Exploration. P. Chalan, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen; J. Bijzet, BS, Department of Rheumatology and Clinical Immunology, University of Groningen; E. Brouwer, MD, PhD, Department of Rheumatology and Clinical Immunology, University of Groningen; A.M. Boots, Prof., Department of Rheumatology and Clinical Immunology, University of Groningen; B.J. Kroesen, PhD, Department of Laboratory Medicine, University of Groningen. Address correspondence to Prof. A.M. Boots, University Medical Center Groningen, Department of Rheumatology and Clinical Immunology, Hanzeplein 1, AA21 Groningen, 9713 GZ, the Netherlands. E-mail: m.boots@umcg.nl. Accepted for publication February 5, 2016.
Article Figures & Data
Additional Files
Data Supplement
Data Supplement
Files in this Data Supplement:
- Data Supplement - Data Supplement
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Altered Natural Killer Cell Subsets in Seropositive Arthralgia and Early Rheumatoid Arthritis are Associated with Autoantibody Status
Paulina Chalan, Johan Bijzet, Bart-Jan Kroesen, Annemieke M.H. Boots, Elisabeth Brouwer
The Journal of Rheumatology Apr 2016, jrheum.150644; DOI: 10.3899/jrheum.150644
Altered Natural Killer Cell Subsets in Seropositive Arthralgia and Early Rheumatoid Arthritis are Associated with Autoantibody Status
Paulina Chalan, Johan Bijzet, Bart-Jan Kroesen, Annemieke M.H. Boots, Elisabeth Brouwer
The Journal of Rheumatology Apr 2016, jrheum.150644; DOI: 10.3899/jrheum.150644